Healthcare -
Biotechnology - NASDAQ - US
$ 1.05
2.94 %
$ 57.8 M
Market Cap
-0.59
P/E
PRLD - TOTAL LIABILITIES
Total Liabilities PRLD - Prelude Therapeutics Incorporated
40.6 M
LAST VALUE
45.37%
2 YEAR CAGR
0.74%
5 YEAR CAGR
0.00%
10 YEAR CAGR